OneGraft

OneGraft is a Danish biotechnology company developing a next-generation synthetic bone graft substitute designed to overcome the limitations of current autografts and synthetic alternatives. The company's proprietary technology utilizes a porous polymer-mineral composite that mimics the structure and mechanical properties of natural bone while promoting rapid integration and remodeling. Their lead product aims to provide a scaffold that supports osteoconduction and potentially osteoinduction for orthopedic and dental applications. By offering a ready-to-use, off-the-shelf solution, OneGraft seeks to eliminate the need for painful bone harvesting procedures and improve patient outcomes in complex reconstructive surgeries. The company is currently focused on advancing its lead candidate through pre-clinical validation and regulatory pathways.